Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thievon-Wright Consulting Group is a specialized clinical research site management and consulting organization focused on Central Nervous System (CNS) disorders. Founded in 1999, the company provides comprehensive services for Phase I-IV clinical trials, including protocol development, site selection, and patient recruitment strategies. They represent a network of elite clinical research sites and offer deep expertise in psychiatry and neurology. In 2014, the company was acquired by Evolution Research Group (ERG), where it continues to operate as a key component of one of the largest independent clinical site networks in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thievon-Wright Consulting Group.